ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,314, issued on April 7, was assigned to R.P. Scherer Technologies LLC (Carson City, Nev.).
"Antibody specific for GPC3 and methods of use thereof" was invented by David Rabuka (Kensington, Calif.), Penelope M. Drake (Castro Valley, Calif.), Yun Cheol Kim (Walnut Creek, Calif.), Robyn M. Barfield (Emeryville, Calif.) and Maxine Bauzon (Hercules, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies specific for glypican-3 (GPC3). Nucleic acids that encode one or both of the variable chain polypeptides of an antibody of the present disclosure are also provided, as are cells that include such nucleic acids. Al...